These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 423925)

  • 21. Antenatal diagnosis of Duchenne muscular dystrophy.
    Emery AE; Burt D; Dubowitz V; Rocker I; Donnai D; Harris R; Donnai P
    Lancet; 1979 Apr; 1(8121):847-9. PubMed ID: 86094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Somatic mosaicism at the Duchenne locus.
    Lebo RV; Olney RK; Golbus MS
    Am J Med Genet; 1990 Oct; 37(2):187-90. PubMed ID: 1978985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Limb-girdle muscular dystrophy in MRI].
    Herzog H; Schröder RJ
    Rofo; 2003 Oct; 175(10):1432-4. PubMed ID: 14556115
    [No Abstract]   [Full Text] [Related]  

  • 24. The diagnostic value of plasma myoglobin levels in the adult and fetus at-risk for Duchenne muscular dystrophy.
    Edwards RJ; Rodeck CH; Watts DC
    J Neurol Sci; 1984 Feb; 63(2):173-82. PubMed ID: 6707690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma creatine kinase and myoglobin levels, before and after abortion, in human fetuses at risk for Duchenne muscular dystrophy.
    Edwards RJ; Rodeck CH; Watts DC
    Am J Med Genet; 1983 Jul; 15(3):475-82. PubMed ID: 6881213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of dystrophin genomic and cDNA probes for solving difficulties in carrier detection and prenatal diagnosis of Duchenne muscular dystrophy.
    Shomrat R; Driks N; Legum C; Shiloh Y
    Am J Med Genet; 1992 Feb; 42(3):281-7. PubMed ID: 1536162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Systematic neonatal screening for Duchenne muscular dystrophy].
    Dellamonica C; Robert JM; Cotte J; Plauchu H; Dorche C
    Nouv Presse Med; 1979 Apr; 8(18):1491-3. PubMed ID: 471723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Differential diagnosis of Becker and Duchenne muscular dystrophy].
    Alvarez Leal M; Hernández Sifuentes PM; Pérez-Zuno JA
    Gac Med Mex; 1994; 130(6):454-8. PubMed ID: 7557060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum creatine kinase isoenzymes in Duchenne muscular dystrophy determined by sensitive enzyme immunoassay methods.
    Mokuno K; Riku S; Sugimura K; Takahashi A; Kato K; Osugi S
    Muscle Nerve; 1987 Jun; 10(5):459-63. PubMed ID: 3302699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fetal plasma carbonic anhydrase III in prenatal diagnosis of Duchenne muscular dystrophy.
    Heath R; Carter ND; Jeffery S; Edwards RJ; Watts DC; Watts RL; Rodeck C
    Am J Med Genet; 1985 Jan; 20(1):115-22. PubMed ID: 3918446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Early clinical and histopathological manifestations in 14 boys showing elevated serum creatine-phosphokinase levels in their first year].
    Guibaud P; Carrier HN; Plauchu H; Lauras B; Jolivet MJ; Robert JM
    J Genet Hum; 1981 Mar; 29(1):71-84. PubMed ID: 7334343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Creatine-kinase (CK) and pyruvate-kinase (PK) activities in cord blood of normal newborn infants: application to Duchenne muscular dystrophy screening programs.
    Passos MR; Zatz M
    Am J Med Genet; 1983 Nov; 16(3):367-72. PubMed ID: 6650572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Screening for elevated creatine kinase activities for the early diagnosis of Duchenne muscular dystrophy].
    Beckmann R; Scheuerbrandt G
    Fortschr Med; 1979 Oct; 97(39):1733-6. PubMed ID: 511067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distal muscular dystrophy.
    Alderson MK; Ziter FA
    Muscle Nerve; 1985 Oct; 8(8):723. PubMed ID: 4058478
    [No Abstract]   [Full Text] [Related]  

  • 35. Prenatal diagnosis and detection of carriers with DNA probes in Duchenne's muscular dystrophy.
    Darras BT; Harper JF; Francke U
    N Engl J Med; 1987 Apr; 316(16):985-92. PubMed ID: 3561454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Creatine phosphokinase alterations in neuromuscular diseases.
    Munsat T
    Isr J Med Sci; 1977 Feb; 13(2):93-7. PubMed ID: 863695
    [No Abstract]   [Full Text] [Related]  

  • 37. [Creatine phosphokinase in differential diagnosis of muscular dystrophies].
    Guglielmetti P
    G Clin Med; 1965 Feb; 46(2):155-64. PubMed ID: 5862841
    [No Abstract]   [Full Text] [Related]  

  • 38. Editorial: Carrier detection in Duchenne type muscular dystrophy.
    Morgan G
    Aust N Z J Med; 1974 Apr; 4(2):196-7. PubMed ID: 4528526
    [No Abstract]   [Full Text] [Related]  

  • 39. A mathematical analysis of creatine kinase activity in the course of Duchenne muscular dystrophy.
    Pernice W; Guggolz MA; Guggolz M; Beckmann R; Wais U
    Muscle Nerve; 1986 May; 9(4):333-40. PubMed ID: 3713738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Serum creatine kinase in normal newborns (author's transl)].
    Gerbaut L; Francoual C; Macart M
    Arch Fr Pediatr; 1981 Dec; 38(10):743-6. PubMed ID: 7332416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.